This tender is from the country of Canada in Americas region. The tender was published by ALBERTA HEALTH SERVICES on 24 May 2025 for The provision of pomalidomide and lenalidomide oncology drugs. The last date to submit your bid for this tender was 19 Jun 2025. This tender is for the companies specializing in Antineoplastic and immunomodulating agents, Antineoplastic agents, Oncology and similar sectors.
*The deadline for this tender has passed.
Tender Organisation:
ALBERTA HEALTH SERVICES
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33652000 : Antineoplastic and immunomodulating agents
33652100 : Antineoplastic agents
33100003 : Oncology
Tender Document Type:
Tender Notice
Tender Description:
The provision of pomalidomide and lenalidomide oncology drugs
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in Antineoplastic and immunomodulating agents, Antineoplastic agents, Oncology? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Canada, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Canada is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33652000, 33652100, 33100003, enabling precise filtering. Search by:
While you're viewing a tender in Canada, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Healthcare & Medical, Canada, and Antineoplastic and immunomodulating agents, Antineoplastic agents, Oncology categories.